Pasithea

Pasithea is a healthcare startup focused on developing a cutting-edge medical device to treat obstructive sleep apnea (OSA), a condition affecting approximately 425 million people globally. The company aims to address the limitations of the current gold standard treatment, continuous positive airway pressure (CPAP), which has a high initial refusal rate and low long-term adherence. Pasithea's technology is designed to be more user-friendly and effective, thereby improving patient compliance and overall quality of life. The company operates in the medical device market, targeting patients with OSA, particularly those with comorbid conditions like diabetes, hypertension, and heart disease. Pasithea's business model involves the development, patenting, and clinical validation of its device, followed by regulatory approval and commercialization. Revenue is generated through the sale of the device to healthcare providers and directly to consumers. The technology has been validated through multiple clinical peer-reviewed publications and is protected by eight patents.

Keywords: obstructive sleep apnea, medical device, CPAP alternative, patient compliance, healthcare startup, sleep disorder, cardiovascular comorbidities, patented technology, clinical validation, user-friendly.